Watchlist Price Alert

Reata Pharmaceuticals Inc... (RETA)

NASDAQ: RETA · Real-Time Price · USD

172.36

0.04 (0.02%)

At close: Sep 25, 2023, 8:00 PM

Reata Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-311.9M	-297.39M	-247.75M	-290.17M	-80.55M	-47.67M	-6.23M
Depreciation & Amortization	1.13M	1.2M	1.14M	932K	431K	437K	682K
Stock-Based Compensation	58.73M	56.81M	57.63M	26.38M	10.55M	6.53M	2.37M
Other Working Capital	4.11M	-58.29M	-175.56M	12.45M	-18.07M	-40.93M	-16.38M
Other Non-Cash Items	38.46M	53.25M	28.14M	1.37M	888K	138K	n/a
Deferred Income Tax	n/a	n/a	11.18M	n/a	1.01M	n/a	n/a
Change in Working Capital	9.31M	-49.58M	-172.68M	10.33M	-16.11M	-42.69M	-16.08M
Operating Cash Flow	-204.27M	-235.7M	-322.34M	-251.15M	-83.78M	-83.26M	-19.26M
Capital Expenditures	-3.27M	-1.33M	-927K	-2.67M	-679K	-344K	-340K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-661.89M	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	320M	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	1K	1K
Investing Cash Flow	-345.16M	-1.33M	-927K	-2.67M	-679K	-343K	-339K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.49M	9.14M	477.09M	580.36M	292.47M	128.65M	62.32M
Financial Cash Flow	1.49M	9.14M	477.09M	580.36M	292.47M	128.65M	62.32M
Net Cash Flow	-547.95M	-227.89M	153.83M	326.53M	208.01M	45.05M	42.72M
Free Cash Flow	-207.54M	-237.03M	-323.27M	-253.82M	-84.46M	-83.6M	-19.6M